Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Jones

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Statistical Methods in Medical Research|June 8, 2019
Dose optimisation with simultaneous pharmacokinetic estimation in adaptive clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones
Pharmaceutical Statistics|December 29, 2018
Properties of the weighted log-rank test in the design of confirmatory studies with delayed effectsJosé L Jiménez, Viktoriya Stalbovskaya, Byron Jones
Pharmaceutical Statistics|April 6, 2020
Response to comments on "Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects" by José L. Jiménez, Viktoriya Stalbovskaya and Byron Jones, Pharmaceutical Statistics, 2019; 18:287-303, DOI: 10.1002/pst.1923José L Jiménez, Viktoriya Stalbovskaya, Byron Jones
British Journal of Clinical Pharmacology|March 26, 2018
An update on the clinical evidence that supports biosimilar approvals in EuropeJohanna Mielke, Bernd Jilma, Byron Jones, et al.
British Journal of Clinical Pharmacology|September 1, 2016
Clinical trials for authorized biosimilars in the European Union: a systematic reviewJohanna Mielke, Bernd Jilma, Franz Koenig, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 6, 2011
Are predictive biomarkers of toxicity worth having? An economic modelByron Jones, Dennis A Smith, Esther F Schmid
Journal of Biopharmaceutical Statistics|December 14, 2004
Estimation of the treatment difference in multicenter trialsValerii Fedorov, Byron Jones, Matthew Jones, et al.
Journal of Biopharmaceutical Statistics|May 27, 2015
Optimizing dose regimens and fixed dose combination ratios in clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones, et al.
The International Journal of Ventilation|May 27, 2024
A comparative analysis of potential aerosol exposure in a wide-body aircraft cabin using tracer gas and fluorescent particlesSeif Mahmoud, James Bennett, Byron Jones, et al.
Statistics in Medicine|March 11, 2003
Kullback-Leibler divergence for evaluating bioequivalenceVladimir Dragalin, Valerii Fedorov, Scott Patterson, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Statistical Methods in Medical Research|June 8, 2019
Dose optimisation with simultaneous pharmacokinetic estimation in adaptive clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones
Pharmaceutical Statistics|December 29, 2018
Properties of the weighted log-rank test in the design of confirmatory studies with delayed effectsJosé L Jiménez, Viktoriya Stalbovskaya, Byron Jones
Pharmaceutical Statistics|April 6, 2020
Response to comments on "Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects" by José L. Jiménez, Viktoriya Stalbovskaya and Byron Jones, Pharmaceutical Statistics, 2019; 18:287-303, DOI: 10.1002/pst.1923José L Jiménez, Viktoriya Stalbovskaya, Byron Jones
British Journal of Clinical Pharmacology|March 26, 2018
An update on the clinical evidence that supports biosimilar approvals in EuropeJohanna Mielke, Bernd Jilma, Byron Jones, et al.
British Journal of Clinical Pharmacology|September 1, 2016
Clinical trials for authorized biosimilars in the European Union: a systematic reviewJohanna Mielke, Bernd Jilma, Franz Koenig, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 6, 2011
Are predictive biomarkers of toxicity worth having? An economic modelByron Jones, Dennis A Smith, Esther F Schmid
Journal of Biopharmaceutical Statistics|December 14, 2004
Estimation of the treatment difference in multicenter trialsValerii Fedorov, Byron Jones, Matthew Jones, et al.
Journal of Biopharmaceutical Statistics|May 27, 2015
Optimizing dose regimens and fixed dose combination ratios in clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones, et al.
The International Journal of Ventilation|May 27, 2024
A comparative analysis of potential aerosol exposure in a wide-body aircraft cabin using tracer gas and fluorescent particlesSeif Mahmoud, James Bennett, Byron Jones, et al.
Statistics in Medicine|March 11, 2003
Kullback-Leibler divergence for evaluating bioequivalenceVladimir Dragalin, Valerii Fedorov, Scott Patterson, et al.
Pageof 4